Skip to main content

Table 1 Baseline Characteristics of Patients Infected With COVID-19

From: Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study

 

Disease severity

PValue

Total (N = 116)

Non-severe (n = 61)

Severe (n = 55)

 

Age, median (IQR), y

58.5 (47.0–69.0)

56.0 (37.0–64.0)

64.0 (53.0–76.0)

<0.001

 0–14 y

0

0

0

–

 15–49 y

33/116 (28.4)

24/61 (39.3)

9/55 (16.4)

–

 50–64 y

41/116 (35.3)

23/61 (37.7)

18/55 (32.7)

–

 ≥ 65 y

42/116 (36.2)

14/61 (23.0)

28/55 (50.9)

–

Sex –No., %

 Female

36/116 (31.0)

19/61 (31.1)

17/55 (30.9)

1.000

 Male

80/116 (69.0)

42/61 (68.9)

38/55 (69.1)

Comorbidities –No., %

 Any

59/116 (50.9)

24/61 (39.3)

35/55 (63.6)

0.009

 COPD

1/116 (0.9)

0/61 (0.0)

1/55 (1.8)

0.290

 Diabetes

19/116 (16.4)

8/61 (13.1)

11/55 (20.0)

0.317

 Hypertension

45/116 (38.8)

19/61 (31.1)

26/55 (47.3)

0.075

 Coronary heart disease

17/116 (14.7)

4/61 (6.6)

13/55 (23.6)

0.009

 Cerebrovascular disease

8/116 (6.9)

1/61 (1.6)

7/55 (12.7)

0.019

 Malignancy

4/116 (3.4)

0/61 (0.0)

4/55 (7.3)

0.032

 Chronic kidney disease

0/116 (0.0)

0/61 (0.0)

0/55 (0.0)

–

 Chronic liver disease

2/116 (1.7)

1/61 (1.6)

1/55 (1.8)

0.941

 HIV infection

0/116 (0.0)

0/61 (0.0)

0/55 (0.0)

–

Signs and symptoms–No., %

 Fever

99/116 (85.3)

49/61 (80.3)

50/55 (91.0)

0.108

 Fatigue

60/116 (51.7)

26/61 (42.6)

34/55 (61.9)

0.039

 Dry cough

61/116 (52.6)

31/61 (50.8)

30/55 (54.5)

0.688

 Anorexia

50/116 (43.1)

27/61 (44.3)

23/55 (41.8)

0.791

 Myalgia

32/116 (27.6)

19/61 (31.1)

13/55 (23.6)

0.366

 Dyspnea

52/116 (44.8)

21/61 (34.4)

31/55 (56.4)

0.018

 Expectoration

31/116 (26.7)

17/61 (27.9)

14/55 (25.5)

0.769

 Hemoptysis

1/116 (0.9)

0/61 (0.0)

1/55 (1.8)

0.290

 Pharyngalgia

15/116 (12.9)

7/61 (11.5)

8/55 (14.5)

0.623

 Nasal obstruction

6/116 (5.2)

4/61 (6.6)

2/55 (3.6)

0.478

 Diarrhea

17/116 (14.7)

14/61 (23.0)

3/55 (5.5)

0.008

 Nausea

10/116 (8.6)

4/61 (6.6)

6/55 (11.0)

0.404

 Dizziness

7/116 (6.0)

2/61 (3.3)

5/55 (9.1)

0.189

 Headache

6/116 (5.2)

5/61 (8.2)

1/55 (1.8)

0.121

 Vomiting

5/116 (4.3)

3/61 (4.9)

2/55 (3.6)

0.734

 Chill

24/116 (20.7)

13/61 (21.3)

11/55 (20.0)

0.901

 Shiver

5/116 (4.3)

3/61 (4.9)

2/55 (3.6)

0.734

 Abdominal pain

3/116 (2.6)

3/61 (4.9)

0/55 (0.0)

0.096

 Chest discomfort

50/116 (43.1)

22/61 (36.1)

28/55 (51.0)

0.107

 Palpitation

13/116 (11.2)

7/61 (11.5)

6/55 (11.0)

0.923

 Sleep disorders

27/116 (23.3)

15/61 (24.6)

12/55 (21.8)

0.724

Onset of symptom to, median (IQR), d

 Hospital admission

8.0 (4.0–11.0)

8.0 (4.0–11.0)

8.0 (4.0–11.0)

0.910

 Dyspnea

4.5 (0.0–9.0)

3.0 (0.0–12.0)

6.0 (1.5–8.5)

0.649

 Heart rate on admission, median (IQR), bpm

86.0 (80.0–98.0)

85.5 (80.0–97.5)

86.0 (80.0–98.0)

0.958

 Respiratory rate on admission, median (IQR)

19.0 (18.0–23.0)

19.0 (18.0–20.0)

20.0 (18.0–25.0)

0.030

 Mean arterial pressure on admission, median (IQR), mmHg

96.7 (86.7–103.3)

96.7 (86.7–103.5)

96.7 (86.7–103.3)

1.000

 Temperature on admission, median (IQR), °C

36.8 (36.5–37.5)

36.7 (36.5–37.3)

37.0 (36.4–37.8)

0.138